Virtus LifeSci Profile

32.48
USD 0.0028  0.0086%
47%
0%

Virtus LifeSci Summary

Virtus LifeSci Biotech Clinical Trls ETF [BBC] is traded in USA and was established on April 19, 2018. The fund is classified under Sector category within BioShares family. Virtus LifeSci Biotech Clinical Trls ETF currently have 75.79 M in assets under management (AUM). , while the total return for the last 3 years was 0.48%.
Check Virtus LifeSci Probability Of Bankruptcy

Geographic Allocation (%)

Sector Allocation (%)

Target Price Odds Analysis

Below OddsHorizonTargetAbove Odds
about 31.31%30 days 32.48  about 68.46%
Based on normal probability distribution, the odds of Virtus LifeSci to move above current price in 30 days from now is about 68.46% (This Virtus LifeSci Biotech Clinical Trls ETF probability density function shows the probability of Virtus LifeSci Etf to fall within a particular range of prices over 30 days) .

Virtus LifeSci Biotech Risk Profiles

Virtus LifeSci Biotech Technical Analysis

Transformation
The output start index for this execution was zero with a total number of output elements of thirty-nine. Virtus LifeSci Biotech Inverse Tangent Over Price Movement function is an inverse trigonometric method to describe Virtus LifeSci price patterns. View also all equity analysis or get more info about inverse tangent over price movement math transform indicator.

Key Fundamentals

Virtus LifeSci Against Markets

Current Ratings

Virtus LifeSci 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
0 
Chance of
Financial Distress (0 to 100%)
< 1% 
Equity ratings for Virtus LifeSci Biotech Clinical Trls ETF are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
The investment seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Clinical Trials Index. Virtus LifeSci is traded on Archipelago Exchange in USA. more
NameVirtus LifeSci Biotech Clinical Trls ETF
Macroaxis Advice
InstrumentUSA Etf View All
RegionNorth America
Investment IssuerBioShares
ExchangeArchipelago Exchange
Etf FamilyBioShares
Fund CategorySector
Portfolio ConcentrationHealth Care
BenchmarkDOW
Contact Number888 383 0553
CurrencyUSD - US Dollar
IssuerBioShares
DescriptionVirtus LifeSci Biotech Clinical Trials ETF
Inception Date2014-12-17
BenchmarkLifeSci Biotechnology Clinical Trials Index
Entity TypeRegulated Investment Company
Asset Under Management75.79 Million
Average Trading Valume23,549
Asset TypeEquity
CategorySector
FocusHealth Care
Market ConcentrationDeveloped Markets
RegionNorth America
AdministratorVirtus ETF Solutions LLC
AdvisorVirtus ETF Advisers LLC
CustodianThe Bank of New York Mellon Corporation
DistributorETF Distributors LLC
Portfolio ManagerMatthew B. Brown, Seth Kadushin
Transfer AgentThe Bank of New York Mellon Corporation
Fiscal Year EndOctober 31
ExchangeNYSE Arca, Inc.
Number of Constituents85.0
Market MakerVirtu Financial
Total Expense0.79
Management Fee0.79

Did you try this?

Run Performance Analysis Now
   

Performance Analysis

Check effects of mean-variance optimization against your current asset allocation
Hide  View All  NextLaunch Performance Analysis

Diversify with Virtus LifeSci Biotech Clinical Trls ETF

Build Optimal Portfolios
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Virtus LifeSci Biotech Clinical Trls ETF to your portfolio
Check also Trending Equities. Please also try Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .